Results 121 to 130 of about 21,433,686 (207)

Assessment of Anti-<i>Toxoplasma gondii</i> Antibodies in Patients with Chronic Hepatitis C Virus Infection: Evaluation of Liver Fibrosis Biomarkers and Elastography Findings. [PDF]

Trop Med Infect Dis
Abdulwehab MM, El Saftawy EA, Elattar S, Hamied AMA, Elgendy SO, Eid AMM, Saleh A, Alzeer R, Gamal M, Eid RA, Mahfoz AM, Fadl HO.   +11 more
europepmc   +1 more source

Gut Microbiota Recovery After Direct-Acting Antiviral Therapy for Chronic Hepatitis C: A Systematic Review and Meta-Analysis. [PDF]

Microorganisms
Hu JH, Chang ML, Huang TJ, Hsieh YY, Liu NJ, Sung KF, Tang JH.   +6 more
europepmc   +1 more source

Antiviral therapy and the risk of extrahepatic malignancies in chronic hepatitis C: insights from recent evidence. [PDF]

Transl Cancer Res
Kanda T, Sasaki-Tanaka R, Terai S.
europepmc   +1 more source

Serum Gremlin 1 Remains Elevated Following Successful Direct-Acting Antiviral Therapy for Chronic Hepatitis C. [PDF]

Viruses
Weigand K, Peschel G, Müller M, Buechler C.   +3 more
europepmc   +1 more source

Steatotic liver disease in patients with chronic hepatitis C. [PDF]

World J Hepatol
Janczura J, Brzdęk M, Flisiak R, Dobrowolska K, Brzdęk K, Rzymski P, Zarębska-Michaluk D.   +6 more
europepmc   +1 more source

Use of Noninvasive Biomarker Tests vs. FibroScan for Predicting Significant Fibrosis in Egyptian Pediatric Cancer Survivors with Chronic Hepatitis C Virus Infection. [PDF]

Pediatr Gastroenterol Hepatol Nutr
Toaima DN, Marzouk FA, El-Haddad A, Elsharkawy A, Esmat GE, El-Sayed MH.   +5 more
europepmc   +1 more source

Observational, Post-marketing Surveillance of Safety and Effectiveness of Glecaprevir/Pibrentasvir in Korean Patients with Chronic Hepatitis C. [PDF]

Infect Dis Ther
Lee JW, Ahn SH, Park JG, Jeong JY, Yoon KT, Tak WY, Baek YH, Yu SJ, Song MJ, Seo YS, Jeong JY, Heo J.   +11 more
europepmc   +1 more source

[Recent Advances in the Treatment of Chronic Hepatitis C]. [PDF]

Korean J Gastroenterol
Kim SB.
europepmc   +1 more source

Real-world efficacy and safety of sofosbuvir/velpatasvir/voxilaprevir in treatment-naive and treatment-experienced chronic hepatitis c patients: a single-center study. [PDF]

BMC Gastroenterol
Tahmaz A, Üser Ü, Keçe MS.
europepmc   +1 more source

Sofosbuvir/Velpatasvir in Chronic Hepatitis C, Compensated and Decompensated Cirrhosis, and Retreatment Settings. [PDF]

Intern Med
Takada H, Tamaki N, Ochi H, Mori N, Tsuji K, Tada T, Nakamura S, Toshimori J, Yoshioka N, Arai H, Fujii H, Hasebe C, Murohisa T, Okamoto E, Kondo M, Marusawa H, Urawa N, Yoshioka T, Yoshida H, Narita R, Akahane T, Kusakabe A, Nonogi M, Imado R, Uchida Y, Sato T, Yokohama K, Kubotsu Y, Ishii T, Izumi N, Kurosaki M.   +30 more
europepmc   +1 more source